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 Abstract 
Background 
Most studies regarding autonomic dysfunction in ischemic stroke are limited to 
heart rate and blood pressure changes during the acute phase. However, there are 
few data on quantitative assessment of autonomic symptoms. We sought to 
assess autonomic symptoms in hypertensive ischemic stroke patients. 
Methods 
In 100 hypertensive patients (45 with symptomatic ischemic stroke (6 months after 
stroke onset) and 55 without stroke), we assessed autonomic symptoms using the 
Scale for Outcomes in Parkinson disease-Autonomic (SCOPA-AUT). 
Results 
The age (mean ± standard deviation) for the stroke group was 66 ± 12 and 63 ± 15 
for the without stroke group (P = 0.8). Orthostatic hypotension occurred in 3.6% of 
the stroke group and 4.4% in the group without stroke. The total SCOPA-AUT 
score was higher in the stroke group compared with the group without stroke (P = 
0.001). Domain scores for gastrointestinal (P = 0.001), urinary (P = 0.005) and 
cardiovascular (P = 0.001) were higher in the stroke group. No differences were 
found when comparing the total SCOPA-AUT scores for stroke subtypes (P = 
0.168) and for lateralization (P = 0.6). SCOPA AUT scores were correlated with 
depression scores (P = 0.001) but not with stroke severity (P = 0.2). 
Conclusion 
Autonomic symptoms, especially, gastrointestinal, urinary and cardiovascular 
function, were significantly increased in hypertensive patients with minor ischemic 
stroke. Symptoms were associated with depression but not with the characteristic 
of the stroke. 
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Introduction 
Autonomic function is frequently altered in patients with ischemic stroke during 
acute and chronic stages. Cardiac arrhythmias and sudden death during acute 
stroke are related to autonomic function imbalance [1], [2] and [3]. Non-invasive 
tests have suggested sympathetic hyperactivity and cardiovagal dysfunction in 
acute stroke [1], [2], [4], [5], [6] and [7] with diverse results when considering the 
influence of lateralization, site and sub-type of ischemic stroke [1], [2], [3] and [8]. 
Autonomic cardiovascular dysfunction is associated with stroke severity [8]. 
Diminished heart rate variability (HRV) and baroreflex sensitivity (BRS) are related 
with worse prognosis [2] and [9]. Gastrointestinal, urinary, sudomotor and sexual 
dysfunction due to multiple factors, including autonomic dysfunction, also occur in 
stroke patients [10], [11], [12], [13], [14], [15], [16], [17] and [18]. Despite clear 
evidence of objective dysfunction in various autonomic domains there is less 
information about the assessment of autonomic symptoms in minor stroke patients. 
We sought to assess autonomic symptoms in hypertensive patients with minor 
ischemic stroke in comparison with hypertensive patients without symptomatic 
ischemic stroke. 
 
  
Patients and Methods 
Consecutive ischemic stroke patients (age ≥18 years old) and hypertensive 
patients without history of symptomatic stroke were recruited from an Outpatient 
clinic. Stroke patients fulfilled the following inclusion criteria; clinical evidence and 
neuroimaging study (computed tomography (CT) or magnetic resonance imaging 
(MRI)) showing a single ischemic lesion based upon AHA/ASA Expert Consensus 
[19]. Presumed etiology of stroke was based on criteria from the Acute Stroke 
Treatment (TOAST) study [20]. Stroke severity was evaluated by means of the 
National Institutes of Health Stroke Scale NIHSS (range 0–42 points) and for global 
disability the modified Rankin scale was used (range 0–6 points) [21]. Clinical 
classification of the sub-type of cerebral infarction was based on the Oxfordshire 
Community Stroke Project (OCSP) criteria; posterior circulation infarct (POCI), 
lacunar infarct (LACI), total anterior circulation infarct (TACI) and partial anterior 
circulation infarct (PACI) [22]. According to the TOAST classification, patients with 
strokes due to cardioembolism, strokes due to other causes (e.g., vasculitis, 
coagulation disorder), and strokes due to unknown or concurrent origin were not 
included. Patients were assessed between 3 and 12 months after their first 
symptomatic stroke. For patients without stroke, the following criteria were used; 
absence of clinical and neuroimaging evidence of ischemic lesion(s). Hypertension 
was defined as a diastolic blood pressure (supine or sitting) of at least 90 mmHg or 
a systolic blood pressure (supine or sitting) of at least 140 mmHg. 
 
For both patient groups a patient with mild global disability (Rankin <3) and any 
neurological disease affecting the autonomic nervous system, like Parkinson's 
disease, multiple system atrophy, pure autonomic failure, autoimmune 
neuropathies, were excluded. 45 stroke patients (17 women, 28 men) and 55 
hypertensive patients without stroke (36 women, 19 men) fulfilled the inclusion 
criteria. 45 age-matched (mean age 64.6 ± 9.8 years, 25 women, 20 men) healthy 
individuals were recruited as a control group for a comparison of SCOPA scores. 
They were screened to have not clinical history of hypertension, stroke or other 
neurological disease, diabetes mellitus, systemic disease affecting autonomic 
nervous system. They were not using medication known to affect autonomic 
function. 
All patients and healthy gave their written informed consent, approved by the 
Ethical Committee of the Hospital and the University of Valparaiso. 
Autonomic nervous system evaluation 
Orthostatic stress testing 
Orthostatic blood pressure (BP) testing was performed in the morning between 10 
and 12 h. Patients were requested to eat a light breakfast no later than 2 h prior to 
the test and abstain from caffeine and alcohol during the previous 12 h. Patients 
laid in the supine position in a quiet room, for 10 min. Patients then assumed the 
upright posture and stood for 10 min. BP and heart rate were measured 
intermittently (DINAMAP monitor, Critikon, Tampa, FL), while the subject was lying 
down and again at 1, 5 and 10 min after standing up. The maximum difference in 
systolic BP from supine to standing was taken as the orthostatic BP change [13]. A 
systolic BP fall ≥20 mmHg was considered as indicative of orthostatic hypotension 
[23]. 
Autonomic symptoms evaluation 
AUT-symptoms were examined using the Scale for Outcomes in Parkinson's 
disease for Autonomic Symptoms (SCOPA-AUT), a questionnaire divided into six 
domains, gastrointestinal (7 items), urinary (6 items), cardiovascular (3 items), 
sudomotor (4 items), pupillomotor (1 item) and sexual in men (2 items). The four 
response options for each item ranged from 0 (never) to 3 (often) with higher total 
scores reflecting worse autonomic functioning [24]. We evaluated symptoms 
related to five domains: gastrointestinal (Gastro), urinary (Uri), cardiovascular 
(Cardio), sudomotor (Sudo) and sexual (in men) (Sex) dysfunction. All questions 
referred to symptoms within the past month. In patients with aphasia the answers 
were obtained from caregivers. We did not explore the Pupillomotor domain. This 
scale has been demonstrated to be reliable and valid [24]. Patients were screened 
for depressive symptoms with the Hamilton depression rating scale (HAM-D); a 
validated method for measuring depression [25]. 
Statistics 
Comparisons were made between groups using Student's independent t tests, 
Fisher's exact tests or Wilcoxon tests, as appropriate. Analysis of variance 
(ANOVA) and post hoc Tukey–Kramer HSD tests were used to compare SCOPA 
scores between groups. Kruskall Wallis tests were used to compare sex scores 
between males. Correlations between SCOPA AUT scores and stroke parameters 
were assessed with Spearman's rank correlations. Significance was set at 0.05. All 
data were analyzed (STATA). 
 
 
  
Results 
Baseline characteristics 
There were no differences in age, body mass index, hyperlipidemia and current 
drug use, between patients with and without stroke (all P > 0.05). Stroke patients 
had a mean NIHSS score of 1.5 ± 2.5 and a mean Rankin score of 0 in 2 and 1–2 
in 43 patients. Half of the stroke patients had a lacunar stroke, according to the 
OCSP classification: LACI = 51.1%, PACI = 31.1%, POCI = 17.8%, TACI 0%. 
Stroke patients showed male predominance, more smokers and diabetics. The 
MMES and HAM-D scores showed worse outcomes in stroke patients (Table 1). 
 
Autonomic evaluation 
The number of stroke patients that reported autonomic symptoms was significantly 
higher than those patients without stroke. Nocturia (37.8%), orthostatic intolerance 
(31.1%), subjective dysphagia (28.9%), increased urinary day time frequency 
(24.4%) and urinary incontinence (24.4%) were among the principal symptoms in 
stroke patients (Table 2). There was no difference in supine BP between groups. 
Orthostatic hypotension occurred in 2 patients with stroke and in 2 patients without 
stroke (Table 2). 
 
SCOPA-AUT scores 
ANOVA analysis indicated significant differences in total SCOPA-AUT, 
gastrointestinal, urinary and cardiovascular scores between groups (with stroke 
and without stroke hypertensive patient groups and healthy subjects). Post hoc 
analysis identified significant differences between hypertensive patients with and 
without stroke in SCOPA total, gastrointestinal, urinary and cardiovascular (P < 
0.01) domains. Also between patients with stroke and healthy subjects in SCOPA 
total, gastrointestinal, urinary, cardiovascular and sudomotor (P < 0.01). Significant 
differences for SCOPA total, urinary, cardiovascular and sudomotor scores (P < 
0.01) were evident between hypertensive patients without stroke and healthy 
subjects. Kruskall Wallis tests did not show a difference in sexual scores between 
the 3 groups (males) (Table 2). 
In the stroke patients group the SCOPA AUT scores correlated significantly with 
HAM-D depression scores (R = 0.6, P = 0.001). There were no significant 
correlations between SCOPA AUT scores and age (R = 0.047), MMSE scores (R = 
−0.1), NIHSS scores (R = 0.186) and Rankin scores (R = 0.131). 
In stroke patients, the total score was not different between patients with and 
without diabetes (P = 0.3). The total SCOPA-AUT score was not different between 
left side and right side hemispheric lateralization (P = 0.6). Total SCOPA-AUT 
scores were not different between OCPS ischemic stroke subtypes: median (IQR) 
for PACI = 11 (10–45), for LACI = 14 (5–18), for POCI = 7 (3.5–10.5) (P = 0.168). 
The following domains did not show significant differences between stroke sub-
types: urinary scores for PACI = 4 (2–6), for LACI = 4 (1–6), for POCI = 1 (0–2) (P 
= 0.122), cardiovascular scores for PACI = 3 (1–5), for LACI = 4 (2–5), for POCI = 
2.5 (1.5–3.5) (P = 0.476), thermoregulatory scores for PACI = 2.5 (0–3), for LACI = 
1 (0–3), for POCI = 2 (0–1) (P = 0.914) and sexual function scores for PACI = 0 (0–
4), for LACI = 0 (0–1), for POCI = 0 (0–1) (P = 0.571). Only the gastrointestinal 
score was higher in patients with PACI (P = 0.025).  
Discussion        
The main findings are that in poststroke patients the total autonomic symptoms 
score and domain scores for gastrointestinal, urinary and cardiovascular function 
were significantly higher than in patients without stroke and that these symptoms 
were associated with depression. Characteristics of stroke, including, severity, 
lateralization and global disability, were not associated with autonomic symptoms. 
Urinary symptoms during post-acute stroke are mainly related with age, severity of 
neurological signs and depression [15], [26] and [27]. A study showed more 
incontinent patients in total anterior circulatory infarction and fewer incontinent 
patients in a lacunar stroke group [15]. We found that nocturia and urge 
incontinence were common in the post stroke period and that the urinary 
symptoms score was associated with depression scores. Regarding cardiovascular 
autonomic symptoms, there is less information about orthostatic intolerance 
symptoms. OH in poststroke patients could be due neurogenic and non-neurogenic 
factors. A study showed that OH was common in elderly stroke patients with 
severe disability [28]. In addition, OH in stroke patients was associated with falls 
[29]. Xiong et al. [6] found that OH was significant in large but not in small vessel 
infarctions. OH was not prevalent in our patients with minor stroke and little 
disability; however, we found that symptoms of orthostatic intolerance that were 
associated with depression scores but not with age and characteristics of stroke. 
 
Gastrointestinal dysfunction in the post stroke period could include dysphagia that 
is detected by clinical and instrumental assessments [12]. Constipation is related 
with clinical severity of stroke and is associated with poor outcome and increased 
hospital length of stay [12]; we did not find significant constipation in minor stroke, 
factors like bedridden and reduced consciousness that may cause constipation, 
were not present in our patients. 
 
Autonomic symptoms in stroke patients are related to neurological and non-
neurological factors. Ischemic lesions involving specific areas of the central 
autonomic network, associated diseases, like diabetes mellitus, and medications 
with autonomic effects could be responsible for autonomic dysfunction. In addition, 
end organ pathology, prolonged immobilization and psychological factors may also 
influence autonomic symptoms. Factors like age, BMI, medication and 
hyperlipidemia did not differ between stroke and non-stroke patients. Our patients 
presented with mild disability and half of them had a lacunar stroke, so 
immobilization did not contribute to autonomic symptoms. Hypertensive patients 
without symptomatic stroke showed significantly higher scores than healthy 
subjects for urinary, cardiovascular and sudomotor domains. Factors like 
medication and presence of silent stroke may contribute to those symptoms; 
hypertension is strongly associated with silent brain infarction that may produce 
subtle deficits in cognitive and physical function [30]. 
 
The limitations of our study included: (1) a small sample size which reduced the 
power to establish an association between autonomic symptoms and 
characteristics of stroke, (2) assessment of autonomic symptoms scores with the 
SCOPA-AUT questionnaire, which was initially developed for Parkinson's disease 
patients [24]. This is a valid instrument which explores the full spectrum of 
autonomic symptoms. Currently, there is not an instrument for the assessment of 
autonomic symptoms in stroke patients. 
 
In conclusion, hypertensive patients with minor stroke had more autonomic 
symptoms than hypertensive patients without stroke. The severity, lateralization 
and subtype of the stroke were not associated with autonomic symptoms scores. 
An association between autonomic and depression symptoms was also found. Our 
study supports the need to perform a quantitative assessment of different 
autonomic symptoms domains, in stroke patients.  
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Table 1 
 
Demographic data and clinical characteristic of hypertensive patients without and 
with symptomatic ischemic stroke 
 
                                          Without stroke              With stroke            P 
                                              (n= 55)                        (n=45) 
 
Age (mean ± SD)              65.2 ± 15.1                   65.8 ± 11.7           0.811a 
Sex,  male (%)                  19 (34.5)                       28 (62.2)               0.009b 
BMI (mean ± SD)              27.2 (3.1)                      26.7 (3.2)              0.44a                                      
Hyperlipidemia (%)           13 (23.6)                       9 (20)                    0.809b         
Diabetes Mellitus (%)        8 (14.6)                        14 (31.1)                0.055b 
Depression n (%)              7 (12.7)                         16 (35.6)               0.009b 
Smoker  n (%)                   14 (25.5)                       23 (51.1)               0.012b                               
MMSE (mean ± SD)          27.9 ± 2.6                     25.8 ± 4.2              0.0025a 
NIHSS (mean ± SD)          0                                   1.54 ± 2.5 
HAM-D median (IQR)        4 (2-6)                           6 (3-9)                  0.0004c               
Β blockers        n (%)         7 (12.7)                         6 (13.3)                0.579b   
ACE inhibitor  n (%)          17 (30.9)                       16 (35.5)               0.389b           
CCB                 n (%)         7(12.7)                          6  (13.3)                0.5b     
Diuretic            n (%)         6 ( 10.9)                        7 (15.6)                 0.347b 
Antidepressant n(%)         3(6.7)                             5(9.1)                   0.8b    
a  Student T test  
b   Fisher exact test  
c  Wilcoxon  
ACE angiotensin-converting enzyme inhibitor 
CCB calcium channel blocker 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 Table Hypertensive patients without and with ischemic stroke referring 
frequent autonomic symptoms n(%) 
 
                                                   Without stroke  With stroke                Pa  
                                                   (n  55)               (n 45) 
Symptoms 
Gastrointestinal domain 
Dysphagia                                  1(1.8)               13(28.9)                      0.0001       
Constipation                               5(9.1)                4(8.9)                         0.645 
Fecal incontinence                     0                       2(4.4)                          0.0000 
Urinary domain 
Nocturia                                      8(14.5)             17(37.8)                      0.0073                    
Incontinence                               5(9.1)               11(24.4)                      0.0351 
Increased day time frequency    4(7.3)               11(24.4)                      0.0171 
Difficulty to voiding                     3(5.5)               6(13.3)                        0.0784 
Cardiovascular domain      
Dizzy or “goofy” on standing      3(5.5)               14(31.1)                      0.0007   
Syncope                                     0                       0 
Sweating domain 
Nocturnal hyperhidrosis             2(3.6)                2(4.4)                          0.574 
Asymmetric sweating                 0                       0   
Sexual domain (men) †                                   
Erection dysfunction                  3(10.7)              9(47.3)                        0.0065 
a Fisher exact test 
† without stroke n = 28, with stroke n = 19  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Orthostatic hypotension and autonomic symptoms scores in hypertensive 
patients without and with symptomatic ischemic stroke 
 
                                                   Without stroke     With stroke         P 
                                                 
Supine SBP mmHg a                 140 (130-150)     138 (124-148)     0.878a           
Orthostatic hypotension n (%)   2 (3.6%)              2 (4.4%)              1c 
Autonomic symptoms a 
Total score                                 6 (2-9)                11 (6-16)              0.001b                                             
Gastrointestinal                          0 (0-1)                2 (0-2)                  0.001b                                             
Urinary                                       1 (0-3)                 3 (1-6)                 0.005b                                             
Cardiovascular                          1 (0-3)                 3 (2-5)                  0.001b                                                 
Thermoregulatory                      1 (0-2)                 2(0-3)                   0.182b                                             
Sexual (men)                             0(0-0)                  0 (0-1)                  0.038b                                            
a median (IQR) 
b Wilcoxon 
c Fisher exact test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
